Business Standard

Second sero survey indicates reduction in infections in Mumbai slums: BMC

The presence of Covid-19 antibodies in samples from slums in the city was found to have decreased by 12% in the second sero survey, the Mumbai civic body said on Thursday

Health workers, DOCTORS, nurses, screening, testing, dharavi, mumbai, coronavirus

Health workers screen the residents of Naik Nagar during a health survey, after detection of some positive cases in Dharavi, Mumbai. Photo: PTI

Press Trust of India Mumbai

The presence of COVID-19

antibodies in samples from slums in the city was found to have decreased by 12 per cent in the second sero survey, the Mumbai civic body said on Thursday.

It indicates that infection spread in slums in the city may have come down, it said in a release here. Presence of anti-bodies in the blood indicates that the person has been exposed to the coronavirus.

The latest survey dislosed that "sero-prevalence" of COVID-19 infection in slums is 45 per cent, compared to 57 per cent in the first sero-survey in the city, a release by the Brihanmumbai Municipal Corporation (BMC) said.

 

The sero-prevalence in buildings was around 18 per cent against 16 per cent in the first survey, it added.

The survey was carried out in wards R-north (Borivali), M-West (Mankhurd and Govandi) and F-North (Worli and Lower Parel) in the second half of August.

"Sero-positivity from the second round, taken together with the current number of reported cases from slum areas in these wards, indicates there could be a reduction in the spread of infection in slum areas," said the BMC.

The sero-prevalence of COVID-19 infection in women was marginally higher than men in both the rounds, it said.

In the second survey, sero-prevalence in the age group above 40 was slightly higher.

"Emerging scientific evidence hints at fall of antibody levels in recovered patients/ asymptomatic patients over a period of time and this might have contributed to the trend between two rounds of sero-survey. The impact of this on immunity, if any, is still unknown," the release said.

Sero-prevalence among health care workers in both the rounds was approximately27 per cent.

The survey had been commissioned by the BMC, NITI- Aayog and the Tata Institute of Fundamental Research (TIFR).

Kasturba Molecular Diagnostic Laboratory, Translational Health Science and Technology Institute (THSTI), A.T.E. Chandra Foundation and IDFC Institute had also partnered in the survey.

Mumbai is one of the worst-affected COVID-19 hotspots in the country with over two lakh cases and nearly 9,000 deaths so far.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 02 2020 | 6:21 AM IST

Explore News